Investigation and management of the monoclonal gammopathy of undetermined significance

Authors:
  • TFThe Haemato‐Oncology Task Force Of The British Society For Haematology And The Uk Myeloma Forum
    The Haemato‐Oncology Task Force Of The British Society For Haematology And The Uk Myeloma Forum

Abstract
Summary: This Good Practice Paper provides recommendations for the diagnosis, risk stratification and management of the monoclonal gammopathy of undetermined significance (MGUS). It describes the recently recognised entity of the monoclonal gammopathy of clinical significance (MGCS), and recommends how it should be managed. The potential for targeted population screening for MGUS is also discussed.
Funding Information
  • British Society for Haematology (Funding for literature search only)

This publication has 32 references indexed in Scilit: